Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome

被引:30
作者
Fábregues, F
Balasch, J
Manau, D
Jiménez, W
Arroyo, V
Creus, M
Rivera, F
Vanrell, JA
机构
[1] Univ Barcelona, Hosp Clin & Prov, Fac Med, IDIBAPS,Dept Obstet & Gynecol, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin & Prov, Fac Med, IDIBAPS,Hormonal Lab, E-08036 Barcelona, Spain
[3] Univ Barcelona, Hosp Clin & Prov, Fac Med, IDIBAPS,Liver Unit,Inst Clin Digest Dis,Dept Med, E-08036 Barcelona, Spain
关键词
haematocrit; leukocytosis; ovarian hyperstimulation syndrome; platelets; renin-aldosterone system;
D O I
10.1093/humrep/13.9.2406
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Previous studies have shown that severe ovarian hyperstimulation syndrome (OHSS) is secondary to circulatory dysfunction due to the simultaneous occurrence of increased vascular permeability and marked arteriolar vasodilation which lead to an intense homeostatic stimulation of the renin-aldosterone and sympathetic nervous systems and antidiuretic hormone (ADH), In the present report, we have investigated the correlation between changes in haematocrit concentration, and white blood cell (WBC) and platelet counts and the severity of OHSS, as assessed by these markers of effective intra-arterial blood volume, in a series of 50 patients. In comparison with recovery values (4-5 weeks after hospital discharge), OHSS patients showed arterial hypotension, tachycardia, oliguria, very high plasma concentrations of renin, aldosterone, norepinephrine and ADH, and increased mean haematocrit values and WBC and platelet counts. The haematocrit concentration values were directly related to the plasma concentrations of vasoactive substances (plasma renin activity, aldosterone, norepinephrine and ADH) during OHSS (P < 0.001), In contrast, no correlation was evident between WBC or platelet counts and neurohormonal measurements during the syndrome. It is concluded that haematocrit, but not WBC or platelet counts, can act as a biological marker of the severity of OHSS as indicated by plasma measurement of volume-dependent endogenous vasoactive substances.
引用
收藏
页码:2406 / 2410
页数:5
相关论文
共 27 条
  • [1] Abramov Y, 1996, HUM REPROD, V11, P1381
  • [2] RISK OF THROMBOEMBOLISM IN RELATION TO AN IN-VITRO FERTILIZATION PROGRAM - 3 CASE-REPORTS
    AUROUSSEAU, MH
    SAMAMA, MM
    BELHASSEN, A
    HERVE, F
    HUGUES, JN
    [J]. HUMAN REPRODUCTION, 1995, 10 (01) : 94 - 97
  • [3] Increased induced monocyte tissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome
    Balasch, J
    Reverter, JC
    Fabregues, F
    Tassies, D
    Ordinas, A
    Vanrell, JA
    [J]. FERTILITY AND STERILITY, 1996, 66 (04) : 608 - 613
  • [4] BALASCH J, 1991, FERTIL STERIL, V56, P1077
  • [5] Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach
    Balasch, J
    Fabregues, F
    Arroyo, V
    Jimenez, W
    Creus, M
    Vanrell, JA
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1996, 75 (07) : 662 - 667
  • [6] BALASCH J, 1995, FERTIL STERIL, V64, P65
  • [7] NEUROHORMONAL AND HEMODYNAMIC-CHANGES IN SEVERE CASES OF THE OVARIAN HYPERSTIMULATION SYNDROME
    BALASCH, J
    ARROYO, V
    FABREGUES, F
    SALO, J
    JIMENEZ, W
    PARE, JC
    VANRELL, JA
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 121 (01) : 27 - 33
  • [8] OVARIAN HYPERSTIMULATION SYNDROME - A REVIEW OF PATHOPHYSIOLOGY
    BERGH, PA
    NAVOT, D
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1992, 9 (05) : 429 - 438
  • [9] BURSTEIN SA, 1983, CLIN HAEMATOL, V17, P1038
  • [10] deMola JRL, 1996, HUM REPROD, V11, P1377